Neuro-Degenerative Disease trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Neuro-Degenerative Disease trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
  NCT04079179 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · District of Columbia: Washington D.C.